The greater a company's earnings, the better its position will be to pay dividends. However, Pfizer's adjusted earnings per ...

Pfizer offers an annual dividend yield of 6.98%, or $1.72 a year. Here's how investors can pocket a regular $500 monthly.

Compared to ABBV, PFE's latest dividend declarations and earnings report reveal growth pressure, high payout ratios, and ...

Tuesday's quarterly earnings release underscored the necessity for new revenue drivers. Although Pfizer exceeded analyst expectations with earnings of $0.87 per share against projections of $0.79, ...

High-yield dividend stocks offer two key benefits. They provide regular cash flow through dividend payments and, when dividends are consistently reinvested, have often outperformed the S&P 500 over ...

Pfizer's 7.5% dividend yield is safe due to revenue growth, cost efficiency, and a stronger balance sheet, making it a strong buy. Pfizer's innovation in R&D, including AI partnerships and new drug ...

Pfizer's 7% dividend yield ranks among the highest in the healthcare sector, nearly triple the average of the S&P 500. The payout ratio has improved to 89% from over 100% in recent quarters, but ...

It's no secret that Pfizer (NYSE: PFE) has been gearing up for a possible split for several years now. And, in its most recent efforts to this effect, the drugmaker has already split its operating ...

Realty Income is a real estate investment trust (REIT), which are companies known for paying high dividends. Pfizer is on a new strategic path since the pandemic, but has paid and increased its ...

Novo Nordisk is raising the stakes in its push to outbid rival Pfizer and acquire the development-stage drugmaker Metsera.